Ten positive clones were isolated from 2 X 106 phage and plaque purified. The cDNA in the phage containing the largest insert has been sequenced and shown to code for human factor X. This cDNA insert contained 1137 base pairs coding for a portion of the light chain of the molecule, a connecting region, the heavy chain, a stop codon, a short 3' noncoding region, and a poly(A) tail. The sequence of A-T-T-A-A-A, which functions as a potential recognition site for polyadenylylation or processing, was present in the 3' end of the coding sequence and preceded the stop codon of TGA by 1 base pair and the poly(A) tail by 14 base pairs. The amino acid sequence deduced from the cDNA indicated that factor X is synthesized as a single-chain polypeptide containing the light and heavy chains connected by an Arg-Lys-Arg tripeptide. The singlechain molecule is then converted to the light and heavy chains by cleavage of two (or more) internal peptide bonds. In plasma, these two chains are linked together by a disulfide bond. The DNA sequence coding for the active site of human factor X showed a high degree of identity with prothrombin and factor IX, two other vitamin K-dependent serine proteases that participate in blood coagulation. These data along with the protein sequence data previously published for the light chain of human factor X establish the complete amino acid sequence for the mature protein present in plasma.
Factor X (Stuart factor) is a vitamin K-dependent glycoprotein that participates in the middle phase of the intrinsic and extrinsic pathways of the blood coagulation cascade (1). The human protein (Mr 58,000) is composed of a light chain (Mr 16,200) and a heavy chain (Mr 42,000) held together by a disulfide bond (2, 3) . The light chains of the human (4) and bovine (5) proteins have been sequenced and shown to contain 11 and 12 residues of y-carboxyglutamic acid, respectively (6, 7). The light chain of factor X also contains one residue of 3-hydroxyaspartic acid (4, 8, 9) . The heavy chain of factor X contains the catalytic site that is highly homologous with other serine proteases present in plasma and pancreas (10) . The heavy chain also contains carbohydrate that is attached to Asn-36 and Thr-300 in the bovine molecule (10, 11) .
During the coagulation process, factor X is converted to factor Xa by the cleavage of a glycopeptide from the aminoterminal end of the heavy chain (12) . This cleavage occurs between Arg-51 and Ile-52 in bovine factor X. In the intrinsic pathway of coagulation, the Arg-Ile bond is cleaved by factor IXa in the presence of factor VIIIa, calcium ions, and phospholipid, and in the extrinsic pathway, it is cleaved by factor VIla in the presence of tissue factor (13, 14) . Once factor X is converted to a serine protease, it in turn converts prothrombin to thrombin in the presence of factor Va, calcium ions, and phospholipid. The two internal peptide bonds cleaved in human prothrombin by factor Xa have been identified as Arg-271/Thr-272 and Arg-320/Ile-321 (15) . Thus, factor Xa is a trypsin-like serine protease that circulates in blood in a precursor or zymogen form. Factor X is synthesized in the liver as a single-chain molecule (16, 17) . Vitamin K is involved in the biosynthesis and is required for the carboxylation of the first 11 glutamic acid residues in the amino-terminal portion of the human molecule. This leads to the formation of y-carboxyglutamic acid (6, 18) . At the present time, little is known about the hydroxylation reaction leading to the formation of f3-hydroxyaspartic acid in factor X. In this manuscript, we report the isolation and characterization of a cDNA coding for human factor X. This clone was isolated from a X phage library containing cDNA inserts prepared from human liver.
MATERIALS AND METHODS
Approximately 2 x 106 phage from a Xgtll cDNA library were screened with an antibody to human factor X by the method of Young and Davis (19, 20) . The Xgtll cDNA library contained DNA inserts prepared from human liver mRNA and was kindly provided by Savio L. C. Woo. Positive clones were isolated and plaque purified, and phage DNA was prepared by the plate-lysate method (21) . Phage DNA was then digested with EcoRI endonuclease, and the cDNA insert was subcloned into plasmid pUC-9 (22 Human factor X was purified to homogeneity from human plasma by procedures described by DiScipio et al. (2, 3) and Pepper and Prowse (24) . Rabbit antiserum and affinity-purified antibodies to human factor X were prepared as described by Canfield and Kisiel (25) for human protein C.
RESULTS AND DISCUSSION Human Factor X cDNA. A human liver cDNA library of 2 x 106 Xgtll phage was screened for cDNAs coding for human factor X employing the antibody screening technique of Young and Davis (19, 20) . Ten positive clones were isolated and each phage was plaque purified. A partial restriction Proc. Natl. Acad Sci USA 81 (1984) 3701 map of the cDNA in the phage containing the largest EcoRI insert is shown in Fig. 1 . This phage (XX-1137) contained an insert of -1100 base pairs (bp). This insert was sequenced by the dideoxy method (23) by using the strategy shown at the bottom of Fig. 1 . The complete nucleotide sequence for this insert is shown in Fig. 2 . . FIG. 3. Amino acid sequence for the light and heavy chains of human and bovine factor X. Dots indicate identity between the two proteins. Dashes were inserted for maximal identity between the two proteins. The solid arrow indicates the site of cleavage in the heavy chain when factor X is converted to factor Xa. The active site residues, including His-94, Asp-137, and Ser-234, are circled. The first amino acid in the light and heavy chains starts with no. 1. This is the same numbering system as previously employed for human and bovine factor X (3, 10) . It differs, however, from that shown in Fig. 2 , where the light chain is attached to the heavy chain by a connecting tripeptide. Taken tor X ends with Arg-139 (4) and the heavy chain begins with the sequence Ser-Val-Ala (3). The cDNA indicates that Arg-139 in the light chain and Ser-1 in the heavy chain are connected by the tripeptide Arg-Lys-Arg. Accordingly, factor X is synthesized as a single chain and the connecting tripeptide is removed during processing by two (or more) internal proteolytic cleavages. These data are consistent with experiments of other workers (16, 17) , who demonstrated that factor X is synthesized and secreted as a single-chain precursor and is converted to the two-chain form that is present in plasma.
The amino acid sequence predicted from the cDNA is in complete agreement with that previously published for the light chain (4) and portions of the heavy chain (3) of human factor X. The sequence for the human protein also shows a high degree of homology with a major portion of bovine factor X, including the active site region and the location of the Cys residues (Fig. 3) (2) .
During the conversion of factor X to factor Xa, a glycopeptide is split from the amino-terminal end of the heavy chain (10, 12) . This cleavage occurs between Arg-52 and Ile-53 of the heavy chain of human factor X. Thus, an activation peptide of 52 amino acids is liberated during the conversion of human factor X to factor Xa. The activation peptide contains two potential Asn carbohydrate binding sites, including Asn-Gln-Thr and Asn-Leu-Ser corresponding to Asn-39 and Asn-49, respectively. The activation peptide is also rich in Asp and Glu, which accounts in part for the marked difference in the electrophoretic mobility of factor X versus factor Xa when this peptide is liberated by minor proteolysis (3).
The heavy chain of factor Xa begins with Ile-53 and the typical sequence of Ile-Val-Gly-Gly. This sequence is found in many different serine proteases present in plasma and pancreas (1) . The heavy chain also contains the three principal amino acids involved in catalysis, including His-94, Asp-137, and Ser-234. The amino acid and DNA sequences surrounding Ser-234 are homologous in many serine proteases, including vitamin K-dependent coagulation factors (15, 28) .
The cDNA isolated in the present investigation is only a partial clone. It lacks the 5' end that codes for the aminoterminal portion of the light chain and a leader sequence that is typical of secreted proteins (29) . In human prothrombin and factor IX, two other vitamin K-dependent coagulation factors that have been cloned thus far, a prepro leader sequence has been identified (15, 28) . Thus, it seems likely that factor X will also contain a prepro leader sequence analogous to prothrombin and factor IX.
The genes for human prothrombin and factor IX show considerable similarity in that the first three intervening sequences occur in essentially the same position (30) . Thus, it will be of interest to compare the gene for human factor X with the two other vitamin K-dependent coagulation factors to see whether or not a similar situation exists for factor X. Also, the availability of a cDNA for factor X makes it possible to examine the DNA of individuals with factor X deficiency to identify specific mutation sites in these genes.
